C17 Globotriaosylceramide (d18:1/17:0) – 500 µg

Brand:
Cayman
CAS:
536745-81-0
Storage:
-20
UN-No:
Non-Hazardous - /

C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides (Item Nos. 24870 | 24871 | 24872) in plasma and urine from patients with Fabry disease by GC-MS.{43015} [Matreya, LLC. Catalog No. 1523]  

 

Available on backorder

SKU: 24876 - 500 µg Category:

Description

A sphingolipid; has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS


Formal name: N-[(1S,2R,3E)-1-[([O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy)methyl]-2-hydroxy-3-heptadecenyl]-heptadecanamide

Synonyms:  ​C17 Ceramide Trihexoside (d18:1/17:0)|N-Heptadecanoyl Ceramide Trihexoside

Molecular weight: 1,038.30

CAS: 536745-81-0

Purity: ≥98%

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Lipid Biochemistry|Sphingolipids